Product Description
Presenting the trending Degarelix for Injection 120 mg, an illustrious solution for androgen deprivation therapy in prostate cancer. This affordable and ravishing product comes in a glass vial with a stopper, ensuring quality and safety. Compatible with standard injection equipment, it offers eminent efficacy with its potent, long-acting gonadotropin-releasing hormone antagonist. Each prescription-only pack contains a single vial, ready for subcutaneous administration after reconstitution with sterile water. Take advantage of our current promotion and experience a superior, approved formulation from a leading distributor, exporter, and supplier in India.
Degarelix for Injection 120 mg Elevated Usage and Guidance
Degarelix is used exclusively in hospital settings for treating advanced prostate cancer. It is administered by healthcare professionals via subcutaneous injection after proper reconstitution with sterile water for injection. The recommended dosage and maximum dose should be determined by the physician based on individual patient requirements. The product is ready-to-use, offering targeted androgen deprivation therapy with eminent efficiency, and is suitable for patients where peptide gonadotropin-releasing hormone antagonists are indicated. Ensure all directions of use are followed precisely for optimal results.
Packaging, Samples & Port Details for Degarelix 120 mg
Every Degarelix for Injection 120 mg package contains one glass vial securely sealed with a stopper, maintaining product integrity until use. We offer sample vials upon request, subject to applicable charge. Product handover happens at the nominated FOB port of your choice, ensuring a seamless distribution process. Our facility ensures packaging meets global standards, supporting both bulk and single-pack orders, fostering reliability for wholesalers, distributors, and exporters alike. Take advantage of our special offer for bulk distributors.
FAQs of Degarelix for Injection 120 mg:
Q: How should Degarelix for Injection 120 mg be administered?
A: Degarelix should only be administered by a healthcare professional through a subcutaneous injection after reconstitution with sterile water. The injection should be given immediately after the powder is dissolved.
Q: What are the main indications for using Degarelix 120 mg?
A: Degarelix is primarily indicated for the treatment of advanced prostate cancer as an androgen deprivation therapy, by acting as a gonadotropin-releasing hormone antagonist.
Q: When should Degarelix not be used?
A: Degarelix should not be used in individuals with known hypersensitivity to Degarelix or any of its components. Consult a physician for specific contraindications.
Q: Where should Degarelix vials be stored before and after reconstitution?
A: Prior to reconstitution, store vials below 30C in their original container, protected from light. After reconstitution, refrigerate at 2C to 8C if necessary, and use immediately.
Q: What is the benefit of using Degarelix for Injection 120 mg over other therapies?
A: Degarelix provides rapid testosterone suppression without the initial surge associated with other therapies, offering patients immediate efficacy and a long-acting profile suitable for ongoing cancer management.
Q: What is the reconstitution process for Degarelix and how soon should it be used?
A: Reconstitute Degarelix with sterile water for injection as per instructions provided. Ensure the solution is used immediately after preparation to maintain stability and efficacy.